Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
Andreas Lammerich, Peter Bias, Beate Gertz Merckle GmbH, Ulm, Germany Background: XM17 is a recombinant human follicle-stimulating hormone (follitropin alfa) for stimulation of multifollicular development in women undergoing controlled ovarian hyperstimulation during assisted reproductive therapy...
Main Authors: | Lammerich A, Bias P, Gertz B |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-07-01
|
Series: | International Journal of Women's Health |
Online Access: | http://www.dovepress.com/phase-1-safety-tolerability-and-pharmacokinetic-study-of-single-ascend-peer-reviewed-article-IJWH |
Similar Items
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01) -
Pharmacokinetics, Tolerability and Pharmacogenetics of DA-8031 After Multiple Ascending Doses in Healthy Male Subjects
by: Hwang S, et al.
Published: (2021-06-01) -
Safety, Tolerability, and Pharmacokinetics of the Mineralocorticoid Receptor Modulator AZD9977 in Healthy Men: A Phase I Multiple Ascending Dose Study
by: Andrew Whittaker, et al.
Published: (2020-03-01) -
Pharmacokinetics of surotomycin from phase 1 single and multiple ascending dose studies in healthy volunteers
by: Gurudatt Chandorkar, et al.
Published: (2017-03-01) -
TCP-XM
by: Jeacle, Karl
Published: (2006)